| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1216 | 2019 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 675 | 2021 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 410 | 2020 |
| Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2 AJ O'brien, JN Fullerton, KA Massey, G Auld, G Sewell, S James, ... Nature medicine 20 (5), 518-523, 2014 | 334 | 2014 |
| Inflammatory and immune responses to surgery and their clinical impact W Alazawi, N Pirmadjid, R Lahiri, S Bhattacharya Annals of surgery 264 (1), 73-80, 2016 | 299 | 2016 |
| Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts M Alexander, AK Loomis, J Van Der Lei, T Duarte-Salles, ... BMC medicine 17, 1-9, 2019 | 293 | 2019 |
| Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease M Alexander, AK Loomis, J Fairburn-Beech, J van der Lei, ... BMC medicine 16, 1-11, 2018 | 278 | 2018 |
| Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes MR Pett, WOF Alazawi, I Roberts, S Dowen, DI Smith, MA Stanley, ... Cancer research 64 (4), 1359-1368, 2004 | 269 | 2004 |
| Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection W Alazawi, M Cunningham, J Dearden, GR Foster Alimentary pharmacology & therapeutics 32 (3), 344-355, 2010 | 264 | 2010 |
| Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults M Alexander, AK Loomis, J van der Lei, T Duarte-Salles, ... bmj 367, 2019 | 243 | 2019 |
| Pharmacology and therapeutic potential of interferons PM George, R Badiger, W Alazawi, GR Foster, JA Mitchell Pharmacology & therapeutics 135 (1), 44-53, 2012 | 211 | 2012 |
| Systematic review: Clostridium difficile and inflammatory bowel disease JR Goodhand, W Alazawi, DS Rampton Alimentary pharmacology & therapeutics 33 (4), 428-441, 2011 | 162 | 2011 |
| Interferon-β treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent … MT Herdman, MR Pett, I Roberts, WOF Alazawi, AE Teschendorff, ... Carcinogenesis 27 (11), 2341-2353, 2006 | 159 | 2006 |
| Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16 W Alazawi, M Pett, B Arch, L Scott, T Freeman, MA Stanley, N Coleman Cancer research 62 (23), 6959-6965, 2002 | 158 | 2002 |
| Improving prevention strategies for cardiometabolic disease N Sattar, JMR Gill, W Alazawi Nature Medicine 26 (3), 320-325, 2020 | 140 | 2020 |
| Methotrexate hepatotoxicity and the impact of nonalcoholic fatty liver disease A Shetty, WK Cho, W Alazawi, WK Syn The American journal of the medical sciences 354 (2), 172-181, 2017 | 83 | 2017 |
| Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease W Alazawi, E Bernabe, D Tai, T Janicki, P Kemos, S Samsuddin, WK Syn, ... PLoS One 12 (12), e0185902, 2017 | 82 | 2017 |
| A global research priority agenda to advance public health responses to fatty liver disease JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ... Journal of hepatology 79 (3), 618-634, 2023 | 70 | 2023 |
| Systemic inflammatory response syndrome after major abdominal surgery predicted by early upregulation of TLR4 and TLR5 R Lahiri, Y Derwa, Z Bashir, E Giles, HDT Torrance, HC Owen, ... Annals of surgery 263 (5), 1028-1037, 2016 | 68 | 2016 |
| Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British … S McPherson, MJ Armstrong, JF Cobbold, L Corless, QM Anstee, ... The lancet Gastroenterology & hepatology 7 (8), 755-769, 2022 | 61 | 2022 |
